Scientists test synthetic nicotine and new Nicotine-Like chemicals in vapers
NCT ID NCT07348224
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study will compare how synthetic nicotine and a nicotine analogue (6-methylnicotine) behave in the body versus traditional tobacco-derived nicotine. Twenty-four regular vapers will vape e-liquids containing these substances, and researchers will measure their levels in the blood and their effects. The goal is to understand if these newer products work the same way as standard nicotine.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
synthetic nicotine (S-nicotine, racemic nicotine) and nicotine analogue 6-methylnicotine
What this could lead to
If successful, this could clarify whether synthetic nicotine and nicotine analogues work like traditional nicotine, informing regulation and product safety.
What could go wrong
This is a small, early-phase study (24 people) that only measures short-term effects. Results may not apply to long-term use or broader populations.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VAPING are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Inselspital
Bern, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••